ArticleImmunoTargets and therapy2025

Combination Therapy with Romiplostim, Danazol, and a Thrombopoietin Receptor Agonist for Immune Restoration in Chronic Refractory Immune Thrombocytopenia: A Case Series.

Shi-Xuan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.